PTC Therapeutics | Ventes

Sales Changement Date
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Alnylam Pharmaceuticals USD 439.72M 310.81M 2023-12
Amgen USD 8.2B 1.29B 2023-12
Biogen USD 2.29B 96.3M 2024-03
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Cytokinetics USD 1.67M 1.29M 2023-12
Daiichi Sankyo JPY 409.62B 37.3B 2024-03
Gilead Sciences USD 7.12B 64M 2023-12
Incyte USD 1.01B 94.32M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
Ironwood Pharmaceuticals USD 117.55M 3.81M 2023-12
Novartis USD 11.83B 54M 2024-03
Pfizer USD 14.25B 1.02B 2023-12
PTC Therapeutics USD 307.06M 110.48M 2023-12
Roche Holding CHF 28.94B 842M 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
TG Therapeutics USD 43.97M 121.84M 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12
Xencor USD 44.69M 14.48M 2023-12



PTC Therapeutics Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.